A.J.S. Rayl's article on the possibility of an oral treatment for multiple sclerosis1 (MS) once again points out the need for new thinking about the causes and treatments for MS. For over 50 years, the public has been inundated with incomplete and misleading information about the nature of MS, its origins, and potential treatments. The "MS industry" has been touting either the infectious (bacterial or viral) or immunological etiology of the disease along with the experimental autoimmune encepha

Although Nejat Düzgünes' critique summarized the major criticisms, there was one that was omitted: "cronyism." However, I should point out that there was nothing in his critique that had not been said before, especially in the '70s, when life scientists were asked for their comments and from which little emerged to change the system. I respectfully suggest that his suggestion is flawed. His alternative to the current grant system would "provide continuous and stable funding for scien